Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contrast media: future aspects.

H J Weinmann1, J Platzek, H Schirmer

  • 1Research Laboratories, Schering AG, Müllerstrasse 178, 13342 Berlin, Germany. hannsjoachim.weinmann@schering.de

European Radiology
|February 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NNMT-driven metabolic reprogramming creates a NAMPT druggable vulnerability and reveals liquid biopsy biomarkers for TKI resistance in EGFR-mutant NSCLC.

Cancer letters·2025
Same author

Lower Extremity Impact and Injury Responses of Male and Female PMHS to High-Rate Vertical Loading.

Annals of biomedical engineering·2021
Same author

Aspects of transition cow metabolomics-Part I: Effects of a metaphylactic butaphosphan and cyanocobalamin treatment on the metabolome in liver, blood, and urine in cows with different liver metabotypes.

Journal of dairy science·2021
Same author

Aspects of transition cow metabolomics-Part III: Alterations in the metabolome of liver and blood throughout the transition period in cows with different liver metabotypes.

Journal of dairy science·2021
Same author

Dark Energy Survey Year 1 Results: Cosmological Constraints from Cluster Abundances, Weak Lensing, and Galaxy Correlations.

Physical review letters·2021
Same author

Constraints on Dark Matter Properties from Observations of Milky Way Satellite Galaxies.

Physical review letters·2021
Same journal

Preoperative breast MRI and long-term survival in ductal carcinoma in situ: a propensity score-weighted analysis.

European radiology·2026
Same journal

Efficacy evaluation of artificial intelligence in radiological imaging diagnosis based on randomized controlled trials: a scoping review.

European radiology·2026
Same journal

The bMRI-QUAL scoring system: an important first step toward standardizing breast MRI quality.

European radiology·2026
Same journal

Spectral CT-based habitat analysis for predicting pathologic response to neoadjuvant therapy in gastric cancer.

European radiology·2026
Same journal

MR-guided microwave ablation of liver tumors: outcomes in local tumor control and determinants of treatment success.

European radiology·2026
Same journal

AI integration in pediatric radiology: perspectives from international academic leaders.

European radiology·2026
See all related articles

New contrast agents combining MRI and CT properties offer an innovative alternative to current iodinated contrast media. This hybrid approach may also expand applications in medical imaging and radiotherapy.

Area of Science:

  • Radiology
  • Medical Imaging
  • Contrast Media Development

Background:

  • Computed Tomography (CT) has advanced significantly, yet iodinated contrast media development has seen limited breakthroughs.
  • Existing contrast agents primarily serve diagnostic purposes in CT imaging.

Purpose of the Study:

  • To explore innovative alternatives in contrast media development.
  • To investigate hybrid agents combining Magnetic Resonance Imaging (MRI) and CT properties.

Main Methods:

  • Conceptual exploration of hybrid contrast agent design.
  • Analysis of potential applications beyond traditional CT imaging.

Main Results:

  • Identified a potential for novel hybrid agents integrating MRI and CT functionalities.

Related Experiment Videos

  • Proposed that these agents could offer enhanced imaging capabilities.

    • Conclusions:

    • Hybrid MRI-CT contrast agents represent a promising innovative alternative to current iodinated media.
    • This new approach may lead to expanded clinical indications, including radiotherapy.